Dr. Amit Oza, MD
Claim this profilePrincess Margaret Cancer Centre
About Amit Oza, MD
Education:
- Obtained an MD (Medical Degree) from St. Bartholomew's Hospital, University of London, UK.
- Holds an MBBS (Bachelor of Medicine, Bachelor of Surgery), a standard medical degree in the UK.
Experience:
- Currently serves as the Head of the Department of Medical Oncology & Hematology at Princess Margaret Cancer Centre.
- Acts as the Medical Director of the Cancer Clinical Research Unit and Co-Director of The Bras Drug Development Program at the same institution.
- Holds a position as a Senior Scientist at The Ontario Cancer Institute and a Professor of Medicine at the University of Toronto.
- Has been a principal or co-investigator in over 100 clinical trials focusing on gynecological cancer and advanced colorectal malignancies.
Area of expertise
Ovarian Cancer
Amit Oza, MD has run 22 trials for Ovarian Cancer. Some of their research focus areas include:
Fallopian Tube Cancer
Amit Oza, MD has run 10 trials for Fallopian Tube Cancer. Some of their research focus areas include:
Affiliated Hospitals
Princess Margaret Cancer Centre
University Health Network, Princess Margaret Hospital
Clinical Trials Amit Oza, MD is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting
2 awards
Phase 3
Biomarker Analysis
for Gynecologic Cancers
In recent years, there has been a significant improvement in understanding the biology of cancer and this information has been used to improve cancer care and patient outcome. Research has shown that changes in some genes and/or proteins may be important indicators for certain cancers and response to treatments. Genes are molecules made up of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). DNA contain instructions for the development and functioning of the cells in the body and are passed down from parent to child. RNA is involved with producing proteins in the body. Further research is needed to better understand the changes found in cancer cells and how to target them to stop or reduce cancer growth. A drug that may be able to block certain specific cancer cell changes is called "targeted therapy". Different people with the same type of cancer receiving the same drug could have different responses to it. For example, one person may experience a reduction of their tumor while another person's cancer may worsen. The reason for this is still not well understood and could lie in gene changes. Understanding these changes may allow researchers to predict how treatments may work in guiding decisions around choice of drugs. The purpose of the study is to learn more about gene changes or protein expression (levels) of tumors to better understand the behavior of gynecological diseases and, if possible, better address participants' cancer care now or in the future.
Recruiting
1 award
N/A
6 criteria
More about Amit Oza, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Amit Oza, MD has experience with
- Niraparib
- Paclitaxel
- Carboplatin
- Olaparib
- Mirvetuximab Soravtansine
- Pembrolizumab
Breakdown of trials Amit Oza, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Cancer
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amit Oza, MD specialize in?
Amit Oza, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Amit Oza, MD currently recruiting for clinical trials?
Yes, Amit Oza, MD is currently recruiting for 7 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Amit Oza, MD has studied deeply?
Yes, Amit Oza, MD has studied treatments such as Niraparib, Paclitaxel, Carboplatin.
What is the best way to schedule an appointment with Amit Oza, MD?
Apply for one of the trials that Amit Oza, MD is conducting.
What is the office address of Amit Oza, MD?
The office of Amit Oza, MD is located at: Princess Margaret Cancer Centre, Toronto, Ontario M5G 2M9 Canada. This is the address for their practice at the Princess Margaret Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.